Experimental Ebola vaccine could stop virus in West Africa
LONDON — An experimental vaccine tested on thousands of people in Guinea exposed to Ebola seems to work and might help shut down the ongoing epidemic in West Africa, according to interim results from a study published Friday.
There is currently no licensed treatment or vaccine for Ebola, which has so far killed more than 11,000 people since the world's biggest outbreak began last year.
If proven effective, the vaccine could be "a game-changer," said Dr. Margaret Chan, Director-General of the World Health Organization, which sponsored the trial.
In some 4,000 people who received the vaccine within 10 days of being identified as an Ebola contact, there were no cases of the disease. That compared with 16 cases in more than 3,500 people who only got the shot after 10 days.
Stories that may interest you
Thousands of bikers are pouring into the small South Dakota city of Sturgis as the 80th Sturgis Motorcycle Rally rumbles to life despite fears it could lead to a massive coronavirus outbreak
Financial losses are mounting at the U.S. Postal Service during the coronavirus pandemic
Hispanic children are approximately eight times more likely and Black children five times more likely to be hospitalized with covid-19 than their White peers, according to a study released Friday by the Centers for Disease Control and Prevention.
Alcohol-based hand sanitizers can help stop the coronavirus from spreading, but drinking the products turned out to be deadly for four people in two states